Skip to main content
Clinical Trials/NCT03345758
NCT03345758
Unknown
Not Applicable

Department of Critical Care Medicine, Nanjing Zhong-Da Hospital, Southeast University School of Medicine,China;

Southeast University, China1 site in 1 country80 target enrollmentAugust 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Long-term Outcome
Sponsor
Southeast University, China
Enrollment
80
Locations
1
Primary Endpoint
survival rate
Last Updated
3 years ago

Overview

Brief Summary

Outcomes and Long-term Quality-of-life of Patients requiring Extracorporeal Membrane Oxygenation are not known in china. A prospective study survey will be performed to assess the long-term outcome of these patients.

Detailed Description

Patients admitted to ICUs and treated with extracorporeal membrane oxygenation from March 1,2015 to March 1,2019 were screened . Pre-Ecmo clinical parameters(diagnose,APACHE-II, SOFA,indications,expected mortality) and related treatment conditions(duration of ICU stay, duration of ECMO,duration of mechanical ventilation,ventilation conditions,prone ventilation,ECMO complications )will be used to assess the severity and curative effect of these patients.Short Form-36 Health Status Questionnaire,EuroQol-5 Dimensions and St. George's Respiratory Questionnaire(SGRQ) will deliver in these survivors ,which are used to assess the physical and mental health ,as well as the social adaptation. Finally a comprehensive assessment will be obtained to describe the outcomes and long-term quality-of-life of patients treated With ECMO.

Registry
clinicaltrials.gov
Start Date
August 1, 2017
End Date
December 30, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Southeast University, China
Responsible Party
Principal Investigator
Principal Investigator

Ling Liu

Director

Southeast University, China

Eligibility Criteria

Inclusion Criteria

  • require extracorporeal membrane oxygenation

Exclusion Criteria

  • irreversible disease

Outcomes

Primary Outcomes

survival rate

Time Frame: August,1,2017-March,1,2020

survival rate at discharge

Secondary Outcomes

  • Quality of live(August,1,2017-March,1,2020)
  • Cognitive function(August,1,2017-March,1,2020)

Study Sites (1)

Loading locations...

Similar Trials